Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): A pragmatic, open-label, randomised controlled trial
The Lancet Jan 12, 2019
Naslund U, et al. - A total of 3,532 subjects recruited between April 29, 2013 and June 7, 2016 were assessed to examine the role of ultrasound-based pictorial information regarding subclinical carotid atherosclerosis (targeting both primary care physicians and patients) for prevention of cardiovascular disease in a randomized controlled trial. Individuals aged 40, 50, or 60 years with one or more conventional risk factors were eligible. Researchers observed a decline in Framingham risk score (FRS) from baseline to 1-year follow-up in the intervention group and an increase in the control group. They determined a contributory role of pictorial presentation of silent atherosclerosis for the prevention of cardiovascular disease. They also suggested medication and lifestyle modifications to reduce the prevalence of cardiovascular disease.
To read this article Sign up / Login for free
- Stay on top of policy changes & daily news that matter to you as a healthcare professional
- Update yourself with quick summaries from reputed journals in your specialty
- Earn from paid surveys and influence new developments in healthcare
- Participate in daily quizzes to improve skills and compete with peers
- Save yourself time, as we bring you these and more useful features all at one place!
You get a FREE lifetime membership, with a simple one-time sign up process!